<DOC>
	<DOCNO>NCT01116635</DOCNO>
	<brief_summary>The study design determine whether load doxorubicin ( type chemotherapy ) , load onto drug elute microsphere result increase destruction tumor . The study treat patient surgically resectable liver cancer vary dos doxorubicin load microspheres , close review side effect chemotherapy concentration bloodstream . The tumor surgically remove least 1 month , determine much tumor shrunk , amount tumor destroyed . It hop study result determine treatment role control tumor growth prior surgical removal .</brief_summary>
	<brief_title>Clinical Study Examining Safety Efficacy Doxorubicin Drug Eluting Microspheres Transarterial Embolization Setting Hepatocellular Carcinoma ( HCC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>Patients diagnose surgically resectable hepatocellular carcinoma ( HCC )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>chemoembolization</keyword>
	<keyword>drug elute microsphere</keyword>
	<keyword>hepato</keyword>
	<keyword>embolotherapy</keyword>
	<keyword>downstage</keyword>
</DOC>